Royalty Pharma plc — Director's Dealing 2025

Jan 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Royalty Pharma plc (RPRX)
CIK: 0001802768
Period of Report: 2024-12-31

Reporting Person: Bassler Bonnie L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-31	Class A Ordinary Shares	A	1503	$24.9416	Acquired	61299	Direct

Footnotes

F1: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.